Malignant Oral Cavity Neoplasm

subtype

Identifier: CI-CAN-00003197
Entity page: /cancer/malignant-oral-cavity-neoplasm ↗
Edges: 442

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Malignant Oral Cavity Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 63show all (up to 200)
→ investigated in trials for	Cisplatinsmall molecule 34 trials (14 active) · roll-up of the cancer and its descendants	—	—	Malignant Oral Cavity Neoplasm	34	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumab

Malignant Oral Cavity Neoplasm studied in …STUDIED_INderived10 of 379show all (up to 200)
→ studied in	NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 379 trials mapped (139 active)	—	—	Oral Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ALIAS · 379 trials mapped (139 active)	—	—	Oral Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07844551Phase 2 · not yet recruiting ImmunoADC Therapy for Induction Conversion in Patients With Stage IVB OSCC/OPSCC · condition mapped CURATED_BROADER · 379 trials mapped (139 active)	—	—	Oral Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 379 trials mapped (139 active)	—	—	Oral Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 379 trials mapped (139 active)	—	—	Oral Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped ALIAS · 379 trials mapped (139 active)	—	—	Oral Cavity Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07836829not yet recruiting Risk Factors of Jaw Osteoradionecrosis in Oral Cavity Cancer Patients Post-Radiotherapy · condition mapped CURATED_BROADER · 379 trials mapped (139 active)	—	—	Malignant Oral Cavity Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 379 trials mapped (139 active)	—	—	Oral Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 379 trials mapped (139 active)	—	—	Oral Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07060261NA · recruiting Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 379 trials mapped (139 active)	—	—	Tonsillar Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains